Therefore, we hypothesized that SF3B1 mutations play a central role in MDS-RS pathogenesis, can arise from the more immature HSCs and hence provide a genetic marker to study the clonal evolution from the MDS disease to leukaemic transformation. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.